Gamezumab

N/A

Report date: 2024/11/23 20:00:08

Base Information

Drug NameGamezumab

Drug Alias NameMonoclonal antibodies against Ebola virus disease (Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation)

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsHemorrhagic Fever, Ebola

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryRussian Federation

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesGamaleya Research Institute Of Epidemiology And Microbiology, Health Ministry Of The Russian Federation

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesGamaleya Research Institute Of Epidemiology And Microbiology, Health Ministry Of The Russian Federation

Active IndicationsN/A

Inactive IndicationsHemorrhagic Fever, Ebola

Other Information

ATC CodeN/A